Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience in global measles control, 1990-2001.

Ana-Maria Henao-Restrepo1, Peter Strebel, Edward John Hoekstra

  • 1Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. henaorestrepoa@who.int

The Journal of Infectious Diseases
|May 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing the Diagnostic Time for Childhood Cancer in Peru: A Hospital-Based Registry Analysis Four Years After Implementation of the Global Initiative for Childhood Cancer.

Pediatric blood & cancer·2025
Same author

Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001-2023.

Vaccines·2024
Same author

Changes in reproductive, maternal, and child health in Haiti during the pre- and peri-COVID-19 pandemic.

Revista panamericana de salud publica = Pan American journal of public health·2024
Same author

Considerations in boosting COVID-19 vaccine immune responses.

Lancet (London, England)·2021
Same author

SARS-CoV-2 Variants and Vaccines.

The New England journal of medicine·2021
Same author

COVID-19 vaccine trials: The potential for "hybrid" analyses.

Clinical trials (London, England)·2021

Global measles control efforts in the 1980s achieved high vaccination rates. A 2001 strategic plan aimed to halve measles deaths by 2005 through vaccination campaigns and improved surveillance.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Measles vaccination achieved significant global progress in the 1980s, reaching nearly 80% coverage.
  • Despite progress, an estimated 777,000 measles deaths occurred in 2000, with over half in the WHO African Region.

Purpose of the Study:

  • To outline a strategic plan to reduce global measles mortality.
  • To detail strategies for achieving a 50% reduction in measles deaths by 2005.

Main Methods:

  • Implementing nationwide supplementary immunization activities for a second measles immunization opportunity.
  • Increasing routine measles vaccination coverage rates.
  • Enhancing disease surveillance with laboratory confirmation of suspected cases.

Related Experiment Videos

Main Results:

  • Over 100 million children received measles vaccine via supplementary immunization activities in 2000.
  • Projected increase in supplementary immunization activities from 2002-2005.
  • Need for improved monitoring systems for vaccination coverage and disease burden.

Conclusions:

  • A strategic plan involving supplementary immunization, routine vaccination, and improved surveillance was established to combat measles.
  • Effective monitoring systems are crucial for accurately assessing progress in measles control efforts.
  • Continued efforts are necessary to reduce measles mortality globally.